Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

NCT: NCT07220967 · RECRUITING

NCT IDNCT07220967
StatusRECRUITING
Start Date2025-10-21
Completion2027-10

Brief Summary

The researchers are doing this study to find out whether Stimulan Rapid Cure works to reduce the risk of infections in people getting tissue expanders placed during mastectomy. The researchers will also study whether Stimulan Rapid Cure affects the risk of seroma, a possible complication of surgery that involves fluid buildup under the skin.

Frequently Asked Questions

What is A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement?

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement is a clinical trial registered under NCT07220967. Current status: RECRUITING.

What is the status of NCT07220967?

The current status of NCT07220967 (A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement) is: RECRUITING.

When did A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement start?

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement started on 2025-10-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑